Processa Pharmaceuticals PCSA
NASDAQ PCSA
$1.86 -0.01 (-0.53%)
As of: Nov 12, 2026 · 2:03 PM EST

Processa Pharmaceuticals (PCSA) Sales of Property, Plant and Equipment (2016)

Updated

Processa Pharmaceuticals' Sales of Property, Plant and Equipment came in at $17,000 for FY2016, down 45.3% from $31,100 in FY2015.

Analysis

Processa Pharmaceuticals (PCSA) Sales of Property, Plant and Equipment (2016) Analysis & Trends

  • Per Business Quant, earlier years put Sales of Property, Plant and Equipment at $31,100 in FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -4.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Processa Pharmaceuticals 5.22 Mn -8.52 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 -25,000.00
Jun 30, 2016 15,000.00
Mar 31, 2016 27,000.00
API Access

Processa Pharmaceuticals Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=PCSA&period=max&api_key=YOUR_API_KEY